Device set designed for PCNL surgery

Information

  • Patent Grant
  • 12109382
  • Patent Number
    12,109,382
  • Date Filed
    Saturday, August 22, 2020
    4 years ago
  • Date Issued
    Tuesday, October 8, 2024
    a month ago
Abstract
A device set designed for PCNL surgery includes a puncture needle, a guidewire, a dilator, a balloon catheter, a sheath, and a drainage catheter which are all placed in a single package. A tip length of the dilator is substantially the same as a tip length of the balloon catheter. The device set may include a puncture needle, a guidewire, a plurality of dilators having different sizes, a sheath, and a drainage catheter, which are all placed in a single package, wherein all the dilators have substantially the same tip length.
Description

This application claims the benefit of Chinese Patent Application No. 201910783544.2, filed Aug. 23, 2019, the disclosure of which is incorporated herein by reference.


TECHNICAL FIELD

The present disclosure relates to the percutaneous nephrolithotomy (PCNL) surgery field, in particular, to a device set designed for PCNL surgery.


BACKGROUND

Percutaneous nephrolithotomy, commonly referred to as “drilling holes and removing stones,” is a very effective method of removing and crushing kidney stones. Almost all kidney stones can be removed by percutaneous nephrolithotomy. Successful rate of renal pelvic stone removal is 96-98%, and successful rate of ureteral stone removal is 85%.


For PCNL surgery, there are two common ways to create a nephrostomy tract for removing calculi (i.e., a stone removal path). One way is using balloon dilation catheter to create a tract; and another way is using dilators to create a tract. Current products, especially a balloon dilation product, only includes part of required components. Thus, the physician needs to acquire several packages in order to get all required components, which is very inconvenient.


Moreover, this will also create waste in two aspects. Firstly, a total cost for several separate packages is higher than that for one package. Secondly, different packages will include the same components or extra (undesired) components, which will not be used during surgery (and it is not allowed to sterilize these components and reuse them). Physicians have to discard these components, which will also create waste.


For example, in the method of balloon dilation, physicians have to purchase a balloon dilation catheter set and a fascia dilation device set currently commercially available, in order to perform PCNL surgery with balloon dilation. A balloon dilation catheter kit includes a balloon dilation catheter, a sheath, a two-way valve and an inflation device. A fascia dilation device set includes a puncture needle, a guidewire, dilators of different sizes, a sheath and a drainage catheter. Only one sheath and normally one dilator are needed during a surgery for creating a tract with balloon dilation. The remaining unused new sheath and several unused new dilators have to be discarded after the surgery.


Another problem with existing percutaneous nephrolithotomy lies in that it is very difficult for a physician to insert a dilator/balloon at a right distance. In use, in order to create a uniform channel without causing any unwanted damage to a patient, such a component needs to be put in the right place within a tissue. However, when inserting various components, it is often difficult to ensure the same insertion depth. Too much insertion may cause unwanted injury to the patient; too less insertion may lead to incomplete expansion. This increases the difficulty of surgery.


SUMMARY

One aspect of the present disclosure is to provide a device set designed for percutaneous nephrolithotomy surgery, which set includes all necessary components to facilitate the physicians to use, and is advantageous in wastage and cost reduction.


A further aspect of the disclosure is that, with such a device set, the physician only needs to make sure that a first dilator is in the right place. The other dilators and balloon can follow the same insertion distance as the first dilator, which will greatly decrease the difficulty of surgery and increase the safety of surgery, thereby improving the reliability of surgery.


The present disclosure provides two kinds of device sets designed for PCNL surgery, respectively for the way of balloon catheter dilation and the way of dilator dilation. A device set designed for PCNL surgery using the way of balloon catheter dilation, comprising a puncture needle, a guidewire, a dilator, a balloon catheter, a sheath and a drainage catheter, can be called as a balloon catheter dilation device set. A device set designed for PCNL surgery using the way of dilator dilation, comprising a puncture needle, a guidewire, a plurality of dilators having different sizes, a sheath and a drainage catheter, can be called as a fascia dilation device set.


In either of the above two sets, all the included components can be placed in a single package. A plurality of compartments, for example in the form of recesses, are formed in the package, for accommodating stably the components to prevent the components from any damage caused by colliding with each other during handling.


For the balloon catheter dilation device set, the dilator has a tip length that is substantially the same as a tip length of the balloon catheter; for the fascia dilation device set, all the dilators have substantially the same tip length. Herein, a tip length of the dilator refers to a length of a distal cone portion of the dilator, and a tip length of the balloon catheter refers to a length of a portion between a distal tip of the balloon catheter and a shoulder of a distal cone of the balloon catheter.


By arranging such that the tip lengths are substantially the same, the above-mentioned another problem can be solved, and the above-mentioned another object of the present disclosure can be achieved. The above-mentioned problem arises because, in the existing products, the tips of the dilator and the balloon catheter have different lengths, while the tip portions are non-effective for the dilation of the channel (these portions can be called as a non-effective portion). In use, the insertion of various components often results in inconsistent insertion due to the presence of the tips.


The tip length may be in a range of 0.8 cm to 3 cm, for example 1.2 cm or 2 cm.


In either of the above two device sets, one or more of the puncture needle, guidewire, dilator, balloon catheter, sheath and drainage catheter are provided with scaler markers.


In the above balloon catheter dilation device set, the sheath has a size matched with a size of the balloon catheter; a size of the drainage catheter is 2 Fr less than a size of the balloon catheter.


The balloon catheter dilation device set may further comprise a drainage bag, an inflation device, a stopcock, and/or a securement device. Preferably, the drainage bag may have a volume in a range of 500 ml to 3000 ml.


The above balloon catheter dilation device set may be sized to be 12 Fr, 14 Fr, 16 Fr, 18 Fr, 20 Fr, 22 Fr, 24 Fr, 26 Fr, 28 Fr, 30 Fr, or 32 Fr.


In the above fascia dilation device set, the sheath has a size matched with a size of the dilator having the largest size; a size of the drainage catheter is 2 Fr less than a size of the dilator having the largest size.


The above fascia dilation device set may further comprise a drainage bag and/or a securement device. The drainage bag has a volume in a range of 500 ml to 3000 ml.


The above fascia dilation device set may be sized to be 8 Fr, 10 Fr, 12 Fr, 14 Fr, 16 Fr, 18 Fr, 20 Fr, 22 Fr, 24 Fr, 26 Fr, 28 Fr, 30 Fr, or 32 Fr.


In either of the above two device sets, the sheath may be a common sheath or a tearable sheath.


Other objects, features, and details of the present disclosure can be more fully understood with reference to the following detailed description of exemplary embodiments in conjunction with the accompanying drawings and according to the appended claims. A person skilled in the art will understand advantages of corresponding embodiments and various additional embodiments by reading the following detailed description of the corresponding embodiments with reference to the drawings as listed below. In addition, features in the drawings discussed below are not necessarily drawn to scale. Sizes of the features and elements in the drawings may be appropriately enlarged or reduced to more clearly illustrate the embodiments of the present disclosure.





BRIEF DESCRIPTION OF THE DRAWINGS

The present disclosure is further described as below with reference to the accompanying drawings and embodiments, wherein like reference numerals refer to like elements.



FIG. 1 is an overall schematic view of a balloon catheter dilation device set designed for percutaneous nephrolithotomy surgery according to a first embodiment of the present disclosure.



FIG. 2 is a schematic view of tips of the balloon catheter and of the dilator as shown in FIG. 1 according to the first embodiment of the present disclosure.



FIG. 3 is an overall schematic view of a fascia dilation device set designed for percutaneous nephrolithotomy surgery according to a second embodiment of the present disclosure.



FIG. 4 is a schematic view of a tip of the dilator as shown in FIG. 3 according to the second embodiment of the present disclosure.





DETAILED DESCRIPTION

Various illustrative embodiments of the present disclosure are described below. In this description, for the sake of explanation only, various systems, structures and devices are schematically depicted in the drawings, but all the features of actual systems, structures and devices are not described. For example, well-known functions or structures are not described in detail to avoid unnecessary details to obscure the present disclosure. Of course, it should be understood that in any practical application, many specific implementation decisions need to be made to achieve the specific goals of the developer or user, and the system-related and industry-related restrictions need to be observed. These specific goals may vary with actual applications. In addition, it should be understood that although such specific implementation decisions are complicated and time-consuming, this is a routine task for those of ordinary skill in the art who benefit from the present application.


The terms and phrases used herein should be understood and interpreted as having a meaning consistent with the understanding of those terms and phrases by those skilled in the relevant art. The consistent usage of terms or phrases herein is not intended to imply a specific definition of the term or phrase, that is, a definition that differs from the ordinary and customary meanings understood by those skilled in the art. For terms or phrases intended to have a special meaning, that is, meanings different from those understood by the skilled person, this special meanings will be clearly listed in the description by definition, giving special meanings to the term or phrase directly and unambiguously.


Unless the content requires, throughout the following description and claims, the words “comprising” and its variations, such as “including”, will be interpreted in an open and inclusive sense, that is, as “comprising but not limited to”.


In the present disclosure, the terms “first”, “second”, and the like are used for descriptive purposes only and cannot be construed as indicating relative importance or indicating the number of technical features. Thus, features defined as “first”, “second”, or the like may explicitly or implicitly include one or more of the features. In the description of the present disclosure, the meaning of “a plurality of” is two or more, unless otherwise specified.


In the present disclosure, unless otherwise clearly specified and defined, such terms as “mounted”, “connected”, “coupled”, “fixed”, and so on should be understood in a broad sense. For example, it can be a fixed connection, or a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be directly connected or be indirectly connected via an intermediate medium; or it can be an internal communication between two components. Those of ordinary skill in the art can understand the specific meanings of the above terms in the present disclosure according to specific situations.


In the present disclosure, for convenience of description, the operator (for example, a physician) is used as a reference object, and the side close to the operator is called “proximal”, and the side away from the operator is called “distal”.


First Embodiment

Referring to FIG. 1, the first embodiment according to the present disclosure provides a balloon catheter dilator device set 1 designed for the percutaneous nephrolithotomy surgery.


The balloon catheter dilator set 1 includes or consists of the following components:

    • a) 1 pcs 18 G puncture needle 11;
    • b) 1 pcs 0.035″ or 0.038″ guidewire 12;
    • c) 1 pcs 8 Fr dilator or 1 pcs 10 Fr dilator (only an 8 Fr dilator 13 is shown in the figure);
    • d) 1 pcs balloon catheter 14 having a size the same as a set size of the device set;
    • e) 1 pcs sheath 15 adapted to match with the size of the balloon catheter 14;
    • f) 1 pcs drainage catheter 16 having a size that is 2 Fr less than the size of the balloon catheter 14;
    • g) 1 pcs drainage bag 17 having a volume in a range of 500 ml to 3000 ml;
    • h) 1 pcs inflation device 18;
    • i) 1 pcs stopcock 19; and
    • j) 1 pcs securement device 10.


The set size of the balloon catheter dilation device set 1 may include 12 Fr, 14 Fr, 16 Fr, 18 Fr, 20 Fr, 22 Fr, 24 Fr, 26 Fr, 28 Fr, 30 Fr, or 32 Fr. The set size thereof is an inner diameter of a desired nephrostomy tract (i.e., a stone removal path) that is finally completed.


The balloon catheter 14 has the same specification or nominal size as the set size. For example, as shown in FIG. 1, the balloon catheter dilator device set 1 may have a set size of 24 Fr, in which case it may be referred to as a 24 Fr balloon catheter dilator device set. In the 24 Fr balloon catheter dilator device set, the specification or nominal size of the balloon catheter 14 is 24 Fr, the size of the sheath 15 is 24 Fr, and the size of the drainage catheter 16 is 22 Fr; and the dilator may be selected to be an 8 Fr dilator (as shown in FIG. 1) or a 10 Fr dilator. Physicians can select to use the balloon catheter dilator device sets of different sizes according to patients, conditions, etc.


The device set may include all of the above components, or some of the above components.


The components included in the device set can be placed in a single package P. A plurality of compartments, for example in the form of recesses R, are formed in the package, and can be configured for accommodating stably various components to prevent the components from any damage caused by colliding with each other during handling.


Except for the stopcock and the securement device, all the other components may be provided with scale markers, so as to facilitate the physician to get to know the usage status of the components at any time during use, such as insertion depth, filled volume, inflation pressure, etc.


The sheath may be a common sheath or a tearable sheath.


In particular, in the balloon catheter dilation device set 1, the tip length L of the dilator 13 is substantially the same as the distal tip length L′ of the balloon catheter 14. Herein, as shown in FIG. 2, a tip length of the dilator 13 refers to a length of a distal cone portion of the dilator, and a tip length of the balloon catheter 14 refers to a length of a portion between a distal tip of the balloon catheter and a shoulder of a distal cone of the balloon catheter. The tip length L and L′ may be in a range of 0.8 cm to 3 cm, for example 1.2 cm or 2 cm. The tip length L of the dilator and the tip length L′ of the balloon catheter have a difference less than 4 mm, and can be regarded as being substantially the same length.


During surgery, physician can insert a puncture needle 11 as guided with x-ray and/or ultrasound fluoroscopy. After positioning the puncture needle in place, the physician can record its insertion depth. Then, as guided by the guidewire 12 and with the assistance of scale markers, for example, an 8 Fr dilator or a 10 Fr dilator is inserted, with a dilator insertion depth equal to the puncture needle's insertion depth plus the tip length (for example, the tip length is 1.2 cm). The insertion depth of the subsequently inserted balloon catheter 14 is the same as the insertion depth of the dilator 13.


This device set solves the aforementioned technical problems. In particular, physicians do not need to purchase several packages in order to get all required components, but only need to purchase one set to get ready for all the necessary components, which is very convenient for physicians. Moreover, all the components in the device set are needed during surgery, which will not cause wastage.


In addition, the tips of the dilator and of the balloon catheter in the device set of the present disclosure are designed to have substantially the same length, such that the physicians can easily insert the balloon catheter at the correct distance during use. This greatly reduces the difficulty of surgery, avoids undesirable injuries to the patient, and can ensure the reliability and safety of surgery.


Second Embodiment

Referring to FIG. 3, the second embodiment according to the present disclosure provides a fascia dilation device set 2 designed for the percutaneous nephrolithotomy surgery.


The fascia dilation device set 2 includes or consists of the following components:

    • a) 1 pcs 18 G puncture needle 21;
    • b) 1 pcs 0.035″ or 0.038″ guidewire 22;
    • c) a plurality of dilators 23a-23f having different sizes, the dilators having a number and sizes dependent on the set size of the device set;
    • d) 1 pcs tearable sheath 25 having a size matched with a dilator 23f having the largest size;
    • e) 1 pcs drainage catheter 26 having a size 2 Fr less than the dilator 23f having the largest size;
    • f) 1 pcs drainage bag 27 having a volume in a range of 500 ml to 3000 ml; and
    • g) 1 pcs securement device 20.


The set size of the fascia dilation device set 2 may include 8 Fr, 10 Fr, 12 Fr, 14 Fr, 16 Fr, 18 Fr, 20 Fr, 22 Fr, 24 Fr, 26 Fr, 28 Fr, 30 Fr, or 32 Fr. The set size thereof is an inner diameter of a desired nephrostomy tract (i.e., a stone removal path) that is finally completed. The size of the dilator 23f having the largest size is the same as the set size of the device set. For example, as shown in FIG. 3, the fascia dilation device set 2 may have a set size of 18 Fr, in which case it may be referred to as an 18 Fr fascia dilation device set. Herein, the size of the dilator 23f having the largest size is 18 Fr, the size of the sheath 25 is 18 Fr, and the size of the drainage catheter 26 is 16 Fr; and the sizes of the other dilators 23a to 23e are 8 Fr, 10 Fr, 12 Fr, 14 Fr, 16 Fr in order (in the embodiment shown in FIG. 3, there are six dilators in total, in which the largest size dilator 23f is nested in the sheath 25). Physicians can select to use various balloon catheter dilator device sets of different set sizes according to different patients, different conditions, etc.


The device set may include all of the above components, or some of the above components.


Similar to the first embodiment, the components included in the device set according to the second embodiment can be placed in a single package P. A plurality of compartments, for example in the form of recesses R, are formed in the package, and can be configured for accommodating stably various components to prevent the components from any damage caused by colliding with each other during handling.


Except for the guidewire and the securement device, all the other components may be provided with scale markers, so as to facilitate the physician to get to know the usage status of the components at any time during use, such as insertion depth, filled volume, inflation pressure, etc.


In this embodiment, the sheath is shown to be a tearable sheath. Of course, a non-tearable common sheath may also be used.


In particular, in the fascia dilation device set, the tip lengths L of all the dilators 23a to 23f are substantially the same, as shown in FIG. 4. Herein, a tip length L of the dilator refers to a length of a distal cone portion of the dilator. The tip length L may be in a range of 0.8 cm to 3 cm, for example 2 cm. The tip lengths of different dilators have a difference less than 4 mm, and can be regarded as being substantially the same length.


During surgery, physician can insert a puncture needle 21 as guided with x-ray and/or ultrasound fluoroscopy. After positioning the puncture needle 21 in place, the physician can record its insertion depth. Then, as guided by the guidewire 22 and with the assistance of scale markers, the dilators 23a to 23f are inserted in ascending order, with the insertion depth equal to the puncture needle 21's insertion depth plus the tip length (for example, the tip length is 2 cm).


Like the first embodiment, the device set according to the second embodiment solves the aforementioned technical problems existing in the prior art and produces advantageous technical effects, which will not be repeated here.


The present disclosure may include any feature or combination of features implicitly or explicitly disclosed herein or a generic concept thereof, and is not limited to any defined scope as listed above. Any elements, features and/or structural arrangements described herein may be combined in any suitable manner.


The specific embodiments disclosed above are merely exemplary, and it will be apparent to those skilled in the art who benefit from the teachings herein that the present disclosure can be modified and implemented in different but equivalent manners. For example, steps of the above-mentioned method can be performed in a different order. Further, the details of construction or design shown herein are not limited except those as set forth in the following claims. It is therefore obvious that changes and modifications can be made to the specific embodiments as disclosed above, and all these variations are considered to fall within the scope and spirit of the present disclosure. Therefore, the protection sought herein is set forth in the appended claims.

Claims
  • 1. A device set designed for PCNL surgery, comprising, in a single package: a puncture needle,a guidewire,a dilator including a dilator cone on a distal end of the dilator,a balloon catheter including a balloon catheter cone at a distal portion of the balloon catheter,a sheath, anda drainage catheter,wherein a tip length of the dilator between a proximal end of the dilator cone and a distal end of the dilator cone is the same as a tip length of the balloon catheter between a proximal end of the balloon catheter cone and a distal end of the balloon catheter.
  • 2. The device set according to claim 1, wherein the tip length is in a range of 0.8 cm to 3 cm.
  • 3. The device set according to claim 2, wherein the tip length is 1.2 cm.
  • 4. The device set according to claim 1, wherein a plurality of chambers are formed in the package.
  • 5. The device set according to claim 1, wherein one or more of the puncture needle, the guidewire, the dilator, the balloon catheter, the sheath and the drainage catheter are provided with scale markers.
  • 6. The device set according to claim 1, wherein the sheath has a size corresponding to a size of the balloon catheter.
  • 7. The device set according to claim 1, wherein the sheath of the device set is a tearable sheath.
  • 8. The device set according to claim 1, wherein a size of the drainage catheter is 2 Fr less than a size of the balloon catheter.
  • 9. The device set according to claim 1, further comprising one or more of the following: a drainage bag, an inflator, and a stopcock.
  • 10. The device set according to claim 1, wherein the device set further comprises a drainage bag having a volume in a range of 500 ml to 3000 ml.
Priority Claims (1)
Number Date Country Kind
201910783544.2 Aug 2019 CN national
US Referenced Citations (269)
Number Name Date Kind
4552554 Gould Nov 1985 A
4950257 Hibbs Aug 1990 A
6010520 Pattison Jan 2000 A
6171248 Hossack et al. Jan 2001 B1
6190915 Madsen et al. Feb 2001 B1
6238343 Madsen et al. May 2001 B1
6368277 Mao Apr 2002 B1
6494860 Rocamora Dec 2002 B2
6520934 Lee et al. Feb 2003 B1
6540721 Voyles Apr 2003 B1
6589262 Honebrink Jul 2003 B1
6599237 Singh Jul 2003 B1
6605943 Clark Aug 2003 B1
6647132 Montillo Nov 2003 B1
6663595 Spohn Dec 2003 B2
6673060 Fleming, III Jan 2004 B1
6692464 Graf Feb 2004 B2
6723052 Mills Apr 2004 B2
6733489 Nutting Apr 2004 B2
6736803 Cawood May 2004 B2
6796991 Nardeo May 2004 B2
6748973 Lindroos Jun 2004 B2
6892087 Osypka May 2005 B2
6905458 Choay et al. Jun 2005 B2
6939370 Hartley Sep 2005 B2
7001369 Griffin et al. Feb 2006 B2
7001396 Glazier et al. Feb 2006 B2
7048717 Frassica May 2006 B1
7101353 Lui et al. Sep 2006 B2
7104979 Jansen et al. Sep 2006 B2
7153277 Skujins et al. Dec 2006 B2
7158692 Chalana et al. Jan 2007 B2
7217256 Di Palma May 2007 B2
7258669 Russell Aug 2007 B2
7276062 McDaniel et al. Oct 2007 B2
7306585 Ross Dec 2007 B2
7314481 Karpiel Jan 2008 B2
7322959 Warnack et al. Jan 2008 B2
7462488 Madsen et al. Dec 2008 B2
7481805 Magnusson Jan 2009 B2
7510568 Bleam et al. Mar 2009 B2
7524305 Moyer Apr 2009 B2
7534250 Schaeffer et al. May 2009 B2
7578814 Accisano, III et al. Aug 2009 B2
7591813 Levine et al. Sep 2009 B2
7655021 Brasington et al. Feb 2010 B2
7677078 Sauer et al. Mar 2010 B2
7678100 Chin et al. Mar 2010 B2
7704245 Dittman et al. Apr 2010 B2
7722567 Tal May 2010 B2
7736331 Accisano, III et al. Jun 2010 B2
7780715 Shaked et al. Aug 2010 B2
7794402 Wang Sep 2010 B2
7833597 Bavaro et al. Nov 2010 B2
7857820 Skakoon et al. Dec 2010 B2
7874987 Altmann et al. Jan 2011 B2
7875021 Minassians Jan 2011 B2
7879024 Thorstenson et al. Feb 2011 B2
7909798 Osypka Mar 2011 B2
7909814 Accisano, III et al. Mar 2011 B2
7922696 Tal Apr 2011 B2
7951093 Skujins et al. May 2011 B2
7961929 Ni et al. Jun 2011 B2
7968038 Dittman et al. Jun 2011 B2
7985232 Potter et al. Jul 2011 B2
7993272 Chomas et al. Aug 2011 B2
7993305 Ye et al. Aug 2011 B2
8070694 Galdonik et al. Dec 2011 B2
8105287 Fisher et al. Jan 2012 B2
8137309 Nishtala et al. Mar 2012 B2
8137317 Osypka Mar 2012 B2
8147452 Nardeo et al. Apr 2012 B2
8147456 Fisher et al. Apr 2012 B2
8157790 Kubo et al. Apr 2012 B2
8177770 Rasmussen et al. May 2012 B2
8262671 Osypka Sep 2012 B2
8273059 Nardeo et al. Sep 2012 B2
8287585 Gurm Oct 2012 B2
8292852 Mulholland et al. Oct 2012 B2
8366674 Frassica et al. Feb 2013 B2
8377083 Mauch et al. Feb 2013 B2
8460323 Mauch et al. Jun 2013 B2
8478383 Bar-Tal et al. Jul 2013 B2
8500688 Engel et al. Aug 2013 B2
8517993 Freas et al. Aug 2013 B2
8591567 Chau et al. Nov 2013 B2
8639310 Chen et al. Jan 2014 B2
8652098 Haslinger Feb 2014 B2
8696582 Rohling Apr 2014 B2
8700129 Hauck et al. Apr 2014 B2
8734426 Ahmed et al. May 2014 B2
8753313 Kimmel et al. Jun 2014 B2
8771225 Ahn Jul 2014 B2
8795311 Griffith et al. Aug 2014 B2
8827958 Bierman et al. Sep 2014 B2
8834499 Mauch et al. Sep 2014 B2
8845614 Raabe et al. Sep 2014 B2
8888787 Wynberg Nov 2014 B2
8906268 Boutet et al. Dec 2014 B2
8911400 Ferry Dec 2014 B2
8926560 Dinh et al. Jan 2015 B2
8948474 Chang et al. Feb 2015 B2
8986283 Rajendran et al. Mar 2015 B2
8998814 Oikawa et al. Apr 2015 B2
9044266 Nimgaard Jun 2015 B2
9044577 Bishop et al. Jun 2015 B2
9060756 Bencini et al. Jun 2015 B2
9089672 Hendriksen et al. Jul 2015 B2
9126019 Guo et al. Sep 2015 B2
9149176 Greenberg et al. Oct 2015 B2
9149606 Beissel et al. Oct 2015 B2
9174036 Okamura et al. Nov 2015 B2
9186484 Defossez et al. Nov 2015 B2
9233226 Lampropoulos et al. Jan 2016 B2
9241735 Nishtala et al. Jan 2016 B2
9242076 Burton et al. Jan 2016 B2
9248261 Schweikert et al. Feb 2016 B2
9254146 Massengale et al. Feb 2016 B2
9282945 Smith et al. Mar 2016 B2
9314749 Yagi et al. Apr 2016 B2
9352132 Urie May 2016 B2
9393041 Barker et al. Jul 2016 B2
9398936 Razzaque et al. Jul 2016 B2
9409001 Aggerholm et al. Aug 2016 B2
9420992 Sheldon et al. Aug 2016 B2
9445837 Fulton, III Sep 2016 B2
9474882 Franklin Oct 2016 B2
9492638 McKinnis et al. Nov 2016 B2
9498282 Fernald Nov 2016 B2
9504476 Gulachenski Nov 2016 B2
9517185 Al-Jazaeri Dec 2016 B1
9522253 Gandras et al. Dec 2016 B2
9538981 Rioux et al. Jan 2017 B2
9539415 Racz et al. Jan 2017 B2
9545506 Quigley Jan 2017 B2
9566087 Bierman et al. Feb 2017 B2
9566413 Eberhardt et al. Feb 2017 B2
9629981 Thungana et al. Apr 2017 B2
9655594 Oraevsky et al. May 2017 B2
9668654 Rajendran et al. Jun 2017 B2
9693820 Potter et al. Jul 2017 B2
9706988 Nobles et al. Jul 2017 B2
9717884 Matsumoto et al. Aug 2017 B2
9737284 Kim et al. Aug 2017 B2
9764111 Gulachenski Sep 2017 B2
9764117 Bierman Sep 2017 B2
9773307 Chang et al. Sep 2017 B2
9839770 Linden et al. Dec 2017 B2
9861385 Fulton Jan 2018 B2
9872666 Quearry Jan 2018 B2
9877704 Ogawa Jan 2018 B2
9884169 Bierman et al. Feb 2018 B2
9920188 Vogt et al. Mar 2018 B2
9950158 True et al. Apr 2018 B2
9955940 Coats et al. May 2018 B1
9972082 Holsing et al. May 2018 B2
9980699 Quearry et al. May 2018 B2
10004475 Quearry Jun 2018 B2
10010701 Ahmed et al. Jul 2018 B2
10034655 McKinnis et al. Jul 2018 B2
10074037 Lu et al. Sep 2018 B2
10076307 Coats et al. Sep 2018 B2
10080873 Stapleton et al. Sep 2018 B2
10086174 Crall et al. Oct 2018 B2
10111645 Fearnot et al. Oct 2018 B2
10118027 Seifert et al. Nov 2018 B2
10137020 Treacy et al. Nov 2018 B2
10143455 Lichty, II et al. Dec 2018 B2
10166070 Davies et al. Jan 2019 B2
10169641 Lee et al. Jan 2019 B2
10173033 Leung et al. Jan 2019 B2
10182804 Walters et al. Jan 2019 B2
10183147 Yang et al. Jan 2019 B2
10188371 Madsen et al. Jan 2019 B2
10213582 Garrison et al. Feb 2019 B2
10213583 Klocke et al. Feb 2019 B2
10219788 Tabeie Mar 2019 B2
10220192 Drasler et al. Mar 2019 B2
10226203 Stigall et al. Mar 2019 B2
10226264 McIntosh et al. Mar 2019 B2
10238463 Verstege et al. Mar 2019 B2
10238834 Bridgeman et al. Mar 2019 B2
10249037 Chang et al. Apr 2019 B2
10252028 Katsurada et al. Apr 2019 B2
10265234 Zwierstra Apr 2019 B1
11529522 Bornzin Dec 2022 B2
20020198492 Miller Dec 2002 A1
20080132933 Gerber Jun 2008 A1
20080154206 Guo Jun 2008 A1
20090030370 Nishtala et al. Jan 2009 A1
20100010530 Rhee Jan 2010 A1
20110054381 Van Dam Mar 2011 A1
20110181614 Chang et al. Jul 2011 A1
20110224538 Linares Sep 2011 A1
20130103004 Gray et al. Apr 2013 A1
20130190609 Fischer, Jr. Jul 2013 A1
20130226094 Ahmed et al. Aug 2013 A1
20140180068 Spencer et al. Jun 2014 A1
20140206987 Urbanski et al. Jul 2014 A1
20140221828 McKinnis et al. Aug 2014 A1
20140257090 Fischer, Jr. et al. Sep 2014 A1
20140265024 Quearry Sep 2014 A1
20140276073 Quearry Sep 2014 A1
20150086094 Chang et al. Mar 2015 A1
20150086095 Chang et al. Mar 2015 A1
20150112256 Byrne et al. Apr 2015 A1
20150150586 Aggerholm et al. Jun 2015 A1
20150272542 Shuman et al. Oct 2015 A1
20150273120 Zamarripa et al. Oct 2015 A1
20150320979 Fearnot et al. Nov 2015 A1
20160120509 Syed et al. May 2016 A1
20160128718 Aggerholm et al. May 2016 A1
20160193448 Nardeo et al. Jul 2016 A1
20160223308 Rhee et al. Aug 2016 A1
20160331929 Lampropoulos et al. Nov 2016 A1
20170021139 Bajema et al. Jan 2017 A1
20170032557 Anand et al. Feb 2017 A1
20170049997 Chao et al. Feb 2017 A1
20170095314 Baldwin Apr 2017 A1
20170112528 Crisman et al. Apr 2017 A1
20170135908 Tai et al. May 2017 A1
20170143349 Raabe et al. May 2017 A1
20170151415 Maeda et al. Jun 2017 A1
20170173302 Beasley et al. Jun 2017 A1
20170182297 Lysgaard et al. Jun 2017 A1
20170182304 Bagwell et al. Jun 2017 A1
20170189059 Long, Jr. et al. Jul 2017 A1
20170224967 Gorn et al. Aug 2017 A1
20170232231 Neoh et al. Aug 2017 A1
20170252560 Imran Sep 2017 A1
20170296798 Kume Oct 2017 A1
20170333149 Stigall et al. Nov 2017 A1
20170333682 Nardeo Nov 2017 A1
20170368238 Robinson Dec 2017 A1
20180001063 Aggerholm et al. Jan 2018 A1
20180008237 Venkataraman et al. Jan 2018 A1
20180015277 Stephens et al. Jan 2018 A1
20180036033 Ignagni et al. Feb 2018 A1
20180093073 Shimizu et al. Apr 2018 A1
20180117279 Yachia et al. May 2018 A1
20180126129 McDonough May 2018 A1
20180132821 Dehghan Marvast et al. May 2018 A1
20180169383 Khalaj et al. Jun 2018 A1
20180177980 Khalaj et al. Jun 2018 A1
20180214288 Smouse et al. Aug 2018 A1
20180221649 Mulrooney et al. Aug 2018 A1
20180243046 Scott et al. Aug 2018 A1
20180256849 Linden et al. Sep 2018 A1
20180256907 Katra et al. Sep 2018 A1
20180263595 Goksel et al. Sep 2018 A1
20180272039 Kim et al. Sep 2018 A1
20180289394 Shah Oct 2018 A1
20180296186 Harks et al. Oct 2018 A1
20180296804 Bierman Oct 2018 A1
20180360494 Melsheimer Dec 2018 A1
20190001031 Real et al. Jan 2019 A1
20190015638 Gruba et al. Jan 2019 A1
20190053790 Grover et al. Feb 2019 A1
20190059857 Ogura et al. Feb 2019 A1
20190076166 Bierman et al. Mar 2019 A1
20190076167 Fantuzzi et al. Mar 2019 A1
20190083061 Choi Mar 2019 A1
20190091453 Browne et al. Mar 2019 A1
20190091461 Bonham et al. Mar 2019 A1
20190105466 Schibli et al. Apr 2019 A1
20190105474 Sheibley Apr 2019 A1
20190110795 Koo et al. Apr 2019 A1
20190125318 Sarna et al. May 2019 A1
20190125398 Baldwin et al. May 2019 A1
Foreign Referenced Citations (9)
Number Date Country
201379888 Jan 2010 CN
204485018 Jul 2015 CN
206434630 Aug 2017 CN
2296747 Jul 2015 EP
4754626 Aug 2011 JP
6301909 Mar 2018 JP
WO-9916499 Apr 1999 WO
WO-2017053344 Mar 2017 WO
WO-2017180419 Oct 2017 WO
Non-Patent Literature Citations (2)
Entry
CN 204485018 English Translation (Year: 2015).
CN206434630 U English Translation (Year: 2017).
Related Publications (1)
Number Date Country
20210052876 A1 Feb 2021 US